Â鶹AV

We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at

Ìý

Welcoming New GCI Prof. Heather Melichar: Illuminating T Cell Biology for Cancer Immunotherapy

In the dynamic realm of cancer research, a fresh spark has joined the Rosalind and Morris Goodman Cancer Institute (GCI) to blaze new trails in the field of immunotherapy. Prof. Heather Melichar, an accomplished immunologist, has stepped into the GCI, bringing her unparalleled enthusiasm and expertise to uncover the mysteries of T cell development and function.

Prof. Melichar's academic trajectory has been a symphony of experiences including diverse projects at the Dana-Farber Cancer Institute, the University of California, Berkeley, and the University of Massachusetts Medical School. As she navigated the intricate landscape of immunology, she decided to dedicate her career to untangling the molecular web that governs T cell lineage commitment. Prof. Melichar has done groundbreaking work in T cells’ behavior and interaction with other cells within the complex thymus environment. She thrives on interdisciplinary collaborations, seeking to solve the most challenging scientific puzzles that lie at the intersection of immunology and cancer biology.

"I have always been fascinated by the immune system's incredible adaptability and its potential to tackle various challenges, including cancer. The prospect of rewiring the immune system for therapeutic purposes is both promising and exciting," Prof. Melichar states passionately. Her devotion to harnessing the immune system's power to combat cancer resonates deeply within her research endeavors and aligns with the GCI’s mandate.

Joining the GCI is a natural fit for Prof. Melichar. "The GCI houses some of the brightest minds in cancer research, creating an inspiring environment that elevates one's work. Prof. Morag Park's vision of fostering interdisciplinary collaborations towards a common goal resonated with me profoundly," she shares. As she embarks on this new chapter, Prof. Melichar eagerly anticipates delving into her new role, learning the ropes, and forging connections across the GCI community. "This academic year holds immense promise, and I look forward to meeting everyone at the GCI, establishing new collaborations, and making strides in the field of cancer immunotherapy." She has already begun working alongside several GCI researchers, including Profs. Guojun Chen and Lawrence Kazak, to integrate her understanding in T cell into transformative cancer treatments.

As we extend our warmest welcome to Prof. Heather Melichar, we anticipate witnessing her remarkable journey unfold at the GCI. Her drive, expertise, and collaborative spiritÌýwill undoubtedly shape the future of immunotherapy and cancer research, fostering hope for better treatment strategies.

Contact Information:
Email: heather.melichar [at] mcgill.ca
Lab Location: 713, McIntyre Medical Science Building
Research Areas: T cells, Immunotherapy, Autoimmunity

Back to top